iBio (IBIO) Receivables - Other (2016 - 2021)
iBio (IBIO) has disclosed Receivables - Other for 8 consecutive years, with $15.0 million as the latest value for Q3 2021.
- Quarterly Receivables - Other changed 0.0% to $15.0 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $15.0 million through Sep 2021, changed 0.0% year-over-year, with the annual reading at $60000.0 for FY2019, N/A changed from the prior year.
- Receivables - Other for Q3 2021 was $15.0 million at iBio, roughly flat from $15.0 million in the prior quarter.
- The five-year high for Receivables - Other was $15.0 million in Q1 2017, with the low at $19000.0 in Q1 2020.
- Average Receivables - Other over 5 years is $12.9 million, with a median of $15.0 million recorded in 2017.
- The sharpest move saw Receivables - Other plummeted 99.87% in 2020, then soared 78847.37% in 2021.
- Over 5 years, Receivables - Other stood at $15.0 million in 2017, then changed by 0.0% to $15.0 million in 2018, then changed by 0.0% to $15.0 million in 2019, then changed by 0.0% to $15.0 million in 2020, then changed by 0.0% to $15.0 million in 2021.
- According to Business Quant data, Receivables - Other over the past three periods came in at $15.0 million, $15.0 million, and $15.0 million for Q3 2021, Q1 2021, and Q4 2020 respectively.